Close

Horizon Pharma (HZNP) to Sell European Marketing Rights to PROCYSBI and EMEA Rights to QUINSAIR

May 23, 2017 4:06 PM EDT Send to a Friend
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login